Bzl,Me-D-Ala-OMe*HCl

Bzl,Me-D-Ala-OMe*HCl is a protected D-alanine derivative presented as a hydrochloride salt, featuring a benzyl (Bzl) N-protection, a methyl-substituted D-alanine stereocenter, and a methyl ester (OMe) at the C-terminus. The salt form improves handling of the amino ester by providing a defined protonation state for the amine while retaining the ester functionality for subsequent transformations. The benzyl-protected amine and methyl ester together create a controlled reactivity profile that supports peptide coupling after orthogonal deprotection or activation steps. The compound functions as a chiral amino acid intermediate where stereochemical fidelity at the D-configuration is maintained through downstream fragment assembly and can be carried into peptidomimetic scaffolds or analytical standards.

1. Protected Peptide Building Block

Bzl,Me-D-Ala-OMe*HCl is applied in peptide synthesis workflows where orthogonally protected amino acid building blocks are required for reliable coupling chemistry. The benzyl-protected amine and methyl ester define protected N- and C-terminus equivalents, enabling selective deprotection strategies that can generate a coupling-ready amino functionality while preserving the chiral D-alanine center. The methyl ester handle can be converted into activated carboxyl derivatives for amide bond formation, supporting incorporation into short peptides and peptide analogs. Downstream, the D-configured residue can be used to tune backbone stereochemistry in peptide construction and to prepare stereochemically defined fragments for structure-activity relationship studies.

2. Chiral Amino Acid Intermediate

Bzl,Me-D-Ala-OMe*HCl is suited for chiral synthesis and process chemistry intermediate preparation where stereocontrol at the D-alanine stereocenter is essential. The combination of N-benzyl protection and C-terminal methyl ester provides a stable chiral platform that can be carried through multi-step derivatization, including ester activation, amide formation, and subsequent functional group interconversions. Hydrochloride salt formation supports reproducible handling during intermediate isolation and downstream coupling operations in fine chemical synthesis. The resulting derivatives can serve as chiral building blocks for unnatural amino acid incorporation, fragment assembly, and stereochemically defined reference materials.

3. Peptidomimetic Scaffold Construction

Bzl,Me-D-Ala-OMe*HCl is utilized in peptidomimetic and backbone-modified scaffold generation where D-amino acid residues influence conformational preferences and proteolytic stability profiles. The protected amine and methyl ester enable conversion into amide-linked motifs that can be extended into larger peptide-like structures or cyclizable intermediates. The benzyl group can be removed under conditions compatible with many synthetic sequences, allowing controlled unveiling of the N-terminus for further coupling or conjugation steps. Incorporation of this D-alanine unit supports the construction of stereochemically defined analogs for biochemical research intermediate preparation and molecular design campaigns.

4. Chemical Biology Labeling Precursors

Bzl,Me-D-Ala-OMe*HCl can be used as a precursor in chemical biology contexts that require defined amino acid stereochemistry for labeling and biomolecule modification strategies. The methyl ester and protected amine provide functional handles that can be transformed into reactive carboxyl equivalents or amide-bearing intermediates for subsequent attachment to targeting scaffolds. The hydrochloride salt form supports handling of the amino ester during derivatization sequences aimed at generating conjugation-ready fragments while maintaining the D-configuration. Downstream products derived from this intermediate can be incorporated into labeled peptides, affinity probes, or analytical reagents used to interrogate biomolecular interactions.

5. Pharmaceutical Intermediate Preparation

Bzl,Me-D-Ala-OMe*HCl is relevant to pharmaceutical intermediate preparation and specialty chemical production where protected amino acid derivatives serve as controlled inputs for medicinal chemistry synthesis. The N-benzyl protection and methyl ester functionality support orthogonal transformations that align with common synthetic planning for amide bond construction and subsequent functional group tuning. The defined stereochemistry at the D-alanine center enables incorporation of stereochemically consistent fragments into larger drug-like molecules and peptide-inspired candidates. The compound's protected framework also supports scalable intermediate handling patterns used in process chemistry for manufacturing route design and fine chemical synthesis.

1. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

2. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

3. Myotropic activity of allatostatins in tenebrionid beetles

4. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum